Learn About Memorial Sloan Kettering Cancer Center

Overview of Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) is one of the oldest and largest private cancer research and treatment institutions in the United States. Founded in 1884, it has grown into a major medical facility with locations throughout New York and New Jersey. The center serves approximately 27,000 patients annually and employs more than 3,000 physicians and medical staff members. MSK operates as both a hospital and research institution, meaning patients receive treatment while contributing to ongoing studies that advance cancer medicine.

The cancer center specializes in treating many types of cancer, including breast, lung, prostate, ovarian, pancreatic, and blood cancers. Beyond surgery and chemotherapy, MSK offers additional treatment options such as radiation therapy, immunotherapy, and targeted drug therapies. The institution maintains several distinct locations: the main hospital in Manhattan, satellite treatment centers in New York and New Jersey, and the Evelyn H. Lauder Breast Center. Each location serves different patient populations and offers various services.

MSK operates as a nonprofit organization, meaning revenue generated goes back into patient care and research rather than to outside shareholders. The center receives funding through patient care revenue, philanthropic donations, and research grants. This structure allows MSK to invest heavily in cancer research and treatment innovation. The institution publishes hundreds of scientific papers annually and conducts clinical trials testing new cancer treatments.

Understanding what MSK offers helps patients and families learn about one option for cancer treatment. The center maintains specific policies about patient care, treatment approaches, and how it operates. Learning about these aspects provides information about how large cancer treatment centers function and what services they typically provide.

• MSK treats approximately 27,000 patients each year
• The center has multiple locations across New York and New Jersey
• MSK operates as a nonprofit institution dedicated to cancer research and treatment
• The medical staff includes over 3,000 physicians and healthcare professionals
• The center was established in 1884, making it over 130 years old

Practical Takeaway: MSK is a large, established cancer treatment center that operates multiple locations and combines patient care with research. Patients and families may consider learning about what services different cancer centers offer when exploring treatment options.

How MSK Provides Cancer Treatment

Memorial Sloan Kettering uses a multidisciplinary team approach to cancer treatment. This means doctors from different specialties work together for each patient. For example, a patient with lung cancer may meet with a surgical oncologist, a medical oncologist who prescribes chemotherapy, a radiation oncologist, and a pulmonologist who specializes in lung disease. These doctors collaborate to develop a treatment plan tailored to the patient's specific cancer type, stage, and overall health.

The center offers several types of cancer treatment options. Surgery removes tumors and surrounding tissue. Chemotherapy uses powerful drugs to kill cancer cells throughout the body. Radiation therapy targets tumors with high-energy beams. Immunotherapy helps the patient's own immune system fight cancer cells. Targeted therapy uses drugs designed to attack specific features of cancer cells. MSK also provides supportive care services including pain management, nutrition counseling, mental health support, and rehabilitation services to help patients manage side effects and maintain quality of life during and after treatment.

MSK utilizes advanced technology in treatment delivery. The institution uses computers to plan radiation doses with precision, ensuring maximum damage to cancer while minimizing exposure to healthy tissue. Imaging technology such as PET scans, CT scans, and MRI machines help doctors see tumors in detail and monitor treatment progress. The center maintains operating rooms equipped with modern surgical tools and technology. Laboratory facilities analyze patient samples to identify specific characteristics of each person's cancer, which helps guide treatment decisions.

Patients at MSK receive care coordinated through a patient navigation system. When someone arrives for treatment, a care coordinator helps manage appointments, insurance questions, and connections to support services. Medical records are maintained in electronic systems, allowing different departments to access information and communicate about the patient's progress. This coordination aims to reduce confusion and ensure smooth transitions between different types of treatment.

• MSK uses multidisciplinary teams where doctors from different specialties collaborate on each patient's care
• Treatment options include surgery, chemotherapy, radiation, immunotherapy, and targeted therapy
• The center provides supportive services such as nutrition counseling and mental health support
• Advanced imaging and computer technology guide treatment planning and delivery
• Patient navigation services help coordinate care and connect patients to resources

Practical Takeaway: Large cancer treatment centers like MSK offer multiple treatment types delivered by coordinated teams. Learning how different treatments work together helps patients understand what a comprehensive cancer treatment program may involve.

MSK's Research and Clinical Trials

Research forms a core part of MSK's mission alongside patient treatment. The institution operates one of the largest cancer research programs in the world, with scientists and physicians conducting studies across many cancer types. In 2023, MSK had approximately 1,000 active clinical trials enrolling patients with various cancers. These trials test new drugs, new combinations of existing drugs, new surgical techniques, and new supportive care approaches. Participation in clinical trials allows patients to access experimental treatments that may not yet be widely available elsewhere.

Clinical trials follow strict protocols approved by institutional review boards, which are committees that ensure research follows ethical guidelines and prioritizes patient safety. Patients who participate in trials receive detailed information about what the trial involves, what risks and benefits may exist, and their right to withdraw at any time. MSK maintains specific criteria for each trial regarding patient age, cancer stage, prior treatments, and other factors. Trials are organized into phases: Phase 1 tests safety and dosage, Phase 2 examines effectiveness, Phase 3 compares new treatments to standard treatments, and Phase 4 monitors long-term outcomes in patients already receiving the treatment.

MSK's research laboratories focus on understanding cancer biology at the molecular level. Scientists study how cancer cells grow, divide, and spread. This basic research has led to development of targeted therapies that work against specific mutations found in certain cancers. For example, researchers at MSK helped develop understanding of HER2-positive breast cancer, leading to drugs like Herceptin that specifically target this type. The institution also conducts research in immunotherapy, examining how to strengthen the immune system's ability to recognize and destroy cancer cells.

The center publishes research findings in major medical journals, contributing to the broader medical knowledge base. MSK scientists have authored thousands of publications that other institutions use to advance their own cancer treatment programs. This shared knowledge accelerates progress across the entire field of oncology. Additionally, MSK offers training programs for physicians and scientists from around the world who come to study its research methods and patient care approaches.

• MSK conducts approximately 1,000 active clinical trials at any given time
• Clinical trials test new drugs, drug combinations, surgical techniques, and supportive care methods
• All trials require approval from institutional review boards that prioritize patient safety and ethics
• MSK publishes hundreds of research papers annually in medical journals
• Research findings from MSK inform cancer treatment approaches at other institutions worldwide

Practical Takeaway: Understanding how clinical trials work and what MSK's research contributions are helps inform decisions about cancer treatment options. Patients interested in learning whether experimental treatments exist for their cancer type can explore clinical trial information as part of their research.

MSK's Locations, Services, and Facilities

Memorial Sloan Kettering operates multiple facilities serving patients across a geographic region. The main hospital campus is located in Manhattan on the Upper East Side, occupying several city blocks and housing inpatient beds, operating rooms, chemotherapy infusion centers, and radiation therapy departments. In addition to this main location, MSK operates regional cancer centers in New Jersey and Long Island, bringing some cancer treatment services closer to patients outside Manhattan. These satellite locations typically offer outpatient services such as chemotherapy infusion, radiation therapy, and doctor consultations, though complex surgeries usually take place at the main Manhattan hospital.

The Evelyn H. Lauder Breast Center is a specialized facility dedicated exclusively to breast cancer treatment and research. This center provides screening mammograms, diagnostic imaging, breast biopsies, and comprehensive breast cancer treatment. The facility employs surgeons, medical oncologists